Dominican Republic vs Kenya: Average cost of multi drug-resistant tuberculosis treatment
Dominican Republic
1,650 constant 2022 US$
in 2024
Kenya
1,800 constant 2022 US$
in 2024
Dominican Republic rank
28th
Kenya rank
26th
Average cost of multi drug-resistant tuberculosis treatment over time
- Dominican Republic
- Kenya
How they compare
Kenya currently reports 1,800 constant 2022 US$ against 1,650 constant 2022 US$ in Dominican Republic, a difference of 150 constant 2022 US$.
That makes Kenya's figure about 1.1 times Dominican Republic's.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Kenya ahead.
Dominican Republic ranks 28th and Kenya ranks 26th of 92 countries.
Across the 2 decades both report, Dominican Republic averaged higher in 1 and Kenya in 1.
Head to head by decade
| Decade | Dominican Republic | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,951 constant 2022 US$ | 2,883 constant 2022 US$ | 932.67 constant 2022 US$ | Kenya |
| 2020s | 1,859 constant 2022 US$ | 1,706 constant 2022 US$ | 153 constant 2022 US$ | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Dominican Republic or Kenya?
- Kenya, at 1,800 constant 2022 US$ against 1,650 constant 2022 US$ in Dominican Republic as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Dominican Republic and Kenya?
- 150 constant 2022 US$, with Kenya ahead.
- How many years of comparable data are there for Dominican Republic and Kenya?
- 8 years are reported by both, from 2017 to 2024.
- How do Dominican Republic and Kenya rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Dominican Republic ranks 28th and Kenya ranks 26th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.